Market Movers

China Vanke’s Stock Price Drops to 4.71 HKD, Reflecting a 3.09% Decrease: An In-depth Analysis on Market Performance

By January 17, 2025 No Comments

China Vanke (2202)

4.71 HKD -0.15 (-3.09%) Volume: 175.91M

China Vanke’s stock price stands at 4.71 HKD, experiencing a decrease of -3.09% in the latest trading session, with a high trading volume of 175.91M. The leading real estate company has seen a year-to-date percentage change of -10.96%, reflecting its current market performance.


Latest developments on China Vanke

China Vanke’s Hong Kong shares plummeted 8% today following reports of the CEO’s detention by authorities, as state media confirmed. Speculation over the top executive’s whereabouts caused shares to sink further, with no plans to extend bonds amid the market slump. Despite this, the company’s president checked in with Chinese media and financial institutions, while most of China Vanke’s bonds saw an increase, particularly the ’22 Vanke 04′ which rose by 13%.


A look at China Vanke Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth3
Resilience3
Momentum2
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has received high scores in both the Value and Dividend categories, indicating a positive long-term outlook for the company. With a strong focus on providing value to its investors and consistently paying out dividends, China Vanke (H) is seen as a stable investment option in the property development sector.

While the company scores lower in the Growth, Resilience, and Momentum categories, it still maintains an overall positive outlook. China Vanke (H) may not be experiencing rapid growth or momentum currently, but its strong value and dividend offerings make it a reliable choice for investors looking for stability in their portfolio.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars